We are live on
!
Find out more
First Trust Advisors Portfolio holdings
AUM
$140B
1-Year Est. Return
27.84%
This Fund
S&P 500
This Quarter
Est. Return
+1.3%
1 Year Est. Return
+27.84%
3 Year Est. Return
+78.79%
5 Year Est. Return
+98.89%
10 Year Est. Return
+456.9%
AUM
$38.5B
AUM Growth
+$4.48B
(+13%)
Cap. Flow
+$4.55B
Cap. Flow
% of AUM
11.82%
Top 10 Holdings %
Top 10 Hldgs %
13.89%
Holding
2,364
New
149
Increased
1,180
Reduced
895
Closed
134
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
First Trust NYSE Arca Biotechnology Index Fund
FBT
|
+$275M |
| 2 |
First Trust Health Care AlphaDEX Fund
FXH
|
+$221M |
| 3 |
First Trust Dow Jones Internet Index Fund ETF
FDN
|
+$193M |
| 4 |
First Trust Consumer Staples AlphaDEX Fund
FXG
|
+$188M |
| 5 |
First Trust Consumer Discretionary AlphaDEX Fund
FXD
|
+$179M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PCYC
PHARMACYCLICS INC
PCYC
|
+$230M |
| 2 |
Spectrum Brands
SPB
|
+$81.6M |
| 3 |
Chevron
CVX
|
+$79.8M |
| 4 |
Pfizer
PFE
|
+$66.7M |
| 5 |
K
Kellanova
K
|
+$63.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.09% |
| 2 | Consumer Discretionary | 10.38% |
| 3 | Technology | 9.81% |
| 4 | Consumer Staples | 7.93% |
| 5 | Communication Services | 6.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1626
OSI Systems
OSIS
$3.57B
| $1.61M | ﹤0.01% |
22,710
-6,589
| -22% | -$477K |
|
1627
Sturm, Ruger & Co
RGR
$610M
| $1.61M | ﹤0.01% |
27,989
-69,421
| -71% | -$3.78M |
|
1628
CONMED
CNMD
$1.29B
| $1.61M | ﹤0.01% |
27,555
+14,353
| +109% | +$774K |
|
1629
Brixmor Property Group
BRX
$9.95B
| $1.6M | ﹤0.01% |
69,367
-5,527
| -7% | -$135K |
|
1630
Gentherm
THRM
$1.31B
| $1.6M | ﹤0.01% |
29,179
-16,861
| -37% | -$894K |
|
1631
RLJ Lodging Trust
RLJ
$1.87B
| $1.6M | ﹤0.01% |
53,685
-15,064
| -22% | -$458K |
|
1632
Nokia
NOK
$50.8B
| $1.59M | ﹤0.01% |
232,715
-9,012
| -4% | -$65.7K |
|
|
SSI
1633
DELISTED
Stage Stores Inc
SSI
| $1.59M | ﹤0.01% |
90,933
-4,172
| -4% | -$79.1K |
|
|
VASC
1634
DELISTED
Vascular Solutions Inc
VASC
| $1.59M | ﹤0.01% |
+45,856
| New | +$1.5M |
|
1635
Columbia Banking Systems
COLB
$8.81B
| $1.59M | ﹤0.01% |
48,893
+2,501
| +5% | +$76.3K |
|
1636
Fresenius Medical Care
FMS
$13.2B
| $1.58M | ﹤0.01% |
+38,078
| New | +$1.63M |
|
|
IGTE
1637
DELISTED
IGATE CORPORATION
IGTE
| $1.58M | ﹤0.01% |
33,171
+17,502
| +112% | +$811K |
|
|
CSH
1638
DELISTED
CASH AMERICA INTERNATIONAL INC
CSH
| $1.58M | ﹤0.01% |
60,199
-85,357
| -59% | -$2.27M |
|
|
HTR
1639
DELISTED
Brookfield Total Return Fund Inc
HTR
| $1.57M | ﹤0.01% |
70,224
-2,890
| -4% | -$67.4K |
|
|
CADE
1640
DELISTED
Cadence Bank
CADE
| $1.56M | ﹤0.01% |
60,667
+4,571
| +8% | +$113K |
|
1641
Biglari Holdings Class B
BH
$1.2B
| $1.54M | ﹤0.01% |
5,597
-1,803
| -24% | -$469K |
|
|
SHPG
1642
DELISTED
Shire pic
SHPG
| $1.54M | ﹤0.01% |
6,395
+2,760
| +76% | +$684K |
|
|
CIVI
1643
DELISTED
Civitas Resources
CIVI
| $1.54M | ﹤0.01% |
757
-468
| -38% | -$1.21M |
|
1644
Valley National Bancorp
VLY
$7.93B
| $1.54M | ﹤0.01% |
149,289
+19,184
| +15% | +$187K |
|
|
NFJ
1645
Virtus Dividend, Interest & Premium Strategy Fund
NFJ
$1.41B
| $1.54M | ﹤0.01% |
101,622
+13,032
| +15% | +$208K |
|
|
CKP
1646
DELISTED
CHECKPOINT SYSTEMS INC
CKP
| $1.53M | ﹤0.01% |
150,089
+128,405
| +592% | +$1.35M |
|
|
NVO
1647
Novo Nordisk
NVO
$216B
| $1.53M | ﹤0.01% |
55,718
+32,232
| +137% | +$906K |
|
1648
Daktronics
DAKT
$941M
| $1.52M | ﹤0.01% |
128,389
+76,187
| +146% | +$843K |
|
|
BBL
1649
DELISTED
BHP Group Plc American Depositary Shares (Each representing two Ordinary Shares)
BBL
| $1.52M | ﹤0.01% |
38,501
+14,723
| +62% | +$650K |
|
1650
CubeSmart
CUBE
$9.53B
| $1.52M | ﹤0.01% |
65,490
-17,357
| -21% | -$409K |
|
Similar funds
DAM
First Trust Advisors's Q2 2015 Portfolio in Review
As of Q2 2015, First Trust Advisors held 2,364 positions worth $38.5B, up 13% from $34B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
First Trust Advisors deployed $4.55B of net new capital in Q2 2015, opening 149 new positions and adding to 1,180 existing holdings. Its largest new stake was Agios Pharmaceuticals: 1,079,286 shares worth $120M.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, up from 21% a quarter earlier, followed by Consumer Discretionary and Technology.
On the sell side, the largest reduction was Chevron, an estimated $79.8M trimmed.
- First Trust Advisors's largest Q2 2015 buy was Agios Pharmaceuticals: 1,079,286 shares worth $120M.
- First Trust Advisors added most to First Trust NYSE Arca Biotechnology Index Fund in Q2 2015, an estimated $275M increase.
- First Trust Advisors's biggest Q2 2015 reduction was Chevron, cutting an estimated $79.8M.
- First Trust Advisors fully exited PHARMACYCLICS INC in Q2 2015, selling an estimated $230M.
- First Trust Advisors's ten largest holdings make up 14% of its $38.5B portfolio in Q2 2015.
- First Trust Advisors opened 149 new positions and closed 134 in Q2 2015.
- First Trust Advisors's portfolio value rose 13% quarter-over-quarter to $38.5B.
Based on First Trust Advisors's 13F filing for Q2 2015, filed 4 Aug 2015.